Justin Loke

Apr 7, 2024 | acsjournals.onlinelibrary.wiley.com | Justin Loke |Myriam Labopin |Charles Craddock |Gerard Socie

INTRODUCTION Allogeneic stem cell transplantation (SCT) plays a critical role in the management of acute myeloid leukemia (AML) in reducing the risk of disease relapse through cytotoxicity from the conditioning regimen, as well as through the graft-versus-leukemia (GVL) effect.1-3 To ensure time for this to develop, transplant strategies are premised on allografting patients in complete remission (CR).

Jun 12, 2023 | onlinelibrary.wiley.com | Jenny Byrne |Justin Loke |Vinit Upasani

SHORT REPORT Justin Loke and Vinit Upasani contributed equally as joint first authors. Simon J. Stanworth and David M. Lowe—joint senior authors. Summary Limited data exist on COVID-19 vaccination efficacy in patients with acute myeloid leukemia and myelodysplasia with excess blasts (AML/MDS-EB2). We report results from a prospective study, PACE (Patients with AML and COVID-19 Epidemiology). 93 patients provided samples post-vaccine 2 or 3 (PV2, PV3).